October 18, 2021
October 18, 2021 – TyrvayaTM (varenicline solution – Oyster Pharma) nasal spray 0.03mg has received U.S. FDA approval to treat the signs and symptoms
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Assistance
October 18, 2021
October 18, 2021 – Esteve Pharmaceuticals has received U.S. FDA approval for Seglentis® (celecoxib/tramadol hydrochloride) to manage acute pain in adults that is severe
October 18, 2021
October 18, 2021 – The U.S. FDA has approved ZimhiTM (naloxone HCl) 5mg/0.5mL, a high-dose naloxone injection, to treat opioid overdoses.
October 18, 2021
October 18, 2021 – Bryant Ranch Prepack has issued a recall for one lot of Methocarbamol 500mg Tablets, as the bottles are mislabeled and instead contain Methocarbamol 750mg
October 15, 2021
October 15, 2021 – The U.S. FDA has expanded the indication for Flucelvax® Quadrivalent (influenza vaccine) to prevent the flu (caused by influenza virus subtypes A and B)
October 15, 2021
October 15, 2021 – The U.S. FDA has approved a new indication for Genentech’s Tecentriq® (atezolizumab) for use as an adjuvant treatment following surgery
October 14, 2021
October 14, 2021 – Lupin Pharmaceuticals has recalled all batches of its Irbesartan Tablets USP 75mg, 150mg, and 300mg in the United States, as well as all batches
October 13, 2021
October 13, 2021 – Verzenio® (abemaciclib) is now approved as an adjuvant treatment for HR-positive, HER2-negative, node-positive early breast cancer in adults who are